Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group.
- 1 June 1981
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 63 (6), 1342-1350
- https://doi.org/10.1161/01.cir.63.6.1342
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Cigarette smoking as a risk factor in men with a prior history of myocardial infarctionJournal of Chronic Diseases, 1979
- Natural history of myocardial infarction in the coronary drug project: Long-term prognostic importance of serum lipid levelsThe American Journal of Cardiology, 1978
- Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT)Journal of Chronic Diseases, 1977
- Smoking and mortality among U.S. veteransJournal of Chronic Diseases, 1974
- I. ApologiaCirculation, 1974
- The Coronary Drug ProjectCirculation, 1973
- Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGIONBMJ, 1971
- Sample sizes for medical trials with special reference to long-term therapyJournal of Chronic Diseases, 1968
- Ballistocardiography: Predictor of Coronary Heart DiseaseCirculation, 1968
- The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problemJournal of Chronic Diseases, 1967